The first patients who have coronavirus have enrolled into clinical trials for coronavirus treatments.
Researchers from the University of Oxford have started a new clinical trials to test effectiveness of potential drug treatments for those with coronavirus.
It is thought there might be some existing drugs that could offer some benefits for patients.
An expert panel that advises the chief medical officer in England are recommending Lopinavir-Ritonavir, which is normally used to treat HIV, and the steroid dexamethasone, which is used in a wide range of conditions to reduce inflammation.
Peter Horby, professor of emerging infectious diseases and global health in the Nuffield department of medicine, University of Oxford, and chief investigator for the trial, said: “There is an urgent need for reliable evidence on the best care for patients with Covid-19.
“Providing possible new treatments through a well-designed clinical trial is the best way to get that evidence.”
He added: “All patients will receive the standard full medical care, regardless of which treatment group they are placed in.”
Martin Landray, professor of medicine and epidemiology at the Nuffield department of population health, and deputy chief investigator, added: “The streamlined design of this clinical trial allows consenting patients to be enrolled in large numbers easily and without compromising patient safety or adding significantly to the workload of busy hospitals and their staff.
“In this way we can rapidly assess the value of potential treatments for Covid-19 and provide reliable information on the best ways to treat patients with this disease.”
As a direct result of people across the UK socialising in large groups in Snowdonia, Brighton, Battersea park and many other locations we could now face a full lockdown.
The measures of the lockdown could include movement being restricted by the police or military, with possible curfews implemented to enforce self-isolation.